Tubingen researchers resolve how a plant steroid hormone makes plants grow

NewsGuard 100/100 Score

If one wants to better understand how plants grow, one must analyse the chemistry of life in its molecular detail. Michael Hothorn from the Friedrich-Miescher-Laboratory of the Max Planck Society in T-bingen and his team are doing just that. Their latest work now reveals that a plant membrane receptor requires a helper protein to sense a growth-promoting steroid hormone and to transduce this signal across the cell membrane.

Every cell is surrounded by a greasy cell membrane. Signals from other cells and from the environment must be sensed at the cell surface, transduced across this membrane and translated into a specific response inside the cell. All organisms have evolved membrane receptor proteins to get these complex tasks done, but plant membrane receptors look drastically different from the well-studied players in animals and bacteria. The plant steroid receptor BRI1, which can sense a small steroid hormone promoting plant growth, belongs to the family of leucine-rich repeat (LRR) receptor kinases, which are responsible for most membrane signalling events in plants. It was previously shown that BRI1 directly binds the small steroid hormone with its LRR-domain at the cell surface.

Julia Santiago, a postdoctoral fellow in the Hothorn lab, could now demonstrate that BRI1 requires a helper protein to correctly sense the hormone and transduce the signal across the membrane. The helper SERK1 is a known player in the brassinosteroid signalling pathway, but it came as a surprise to see how early on it is required. By hitting protein crystals containing the ternary BRI1 - steroid hormone - SERK1 complex with intense X-rays, Santiago could see that SERK1 contributes directly to the formation of the hormone binding pocket, with both proteins interacting with the hormone. The steroid thus acts as a molecular glue which promotes association of the BRI1 and SERK1 LRR domains at the cell surface. This then causes interaction of the cytoplasmic kinases domains in the cell interior, which in turn activates a well characterized signalling pathway triggering the growth response.

The interesting feature of SERK1 is that it can help activate several seemingly unrelated plant receptor kinases, which bind vastly different ligands and trigger different responses. The new structures provide a first glimpse on how SERK1 might be able to do that. Instead of shaking hands with BRI1, it only uses a few 'finger tips' to contact the receptor. Other, strictly conserved surface patches remain available for the interaction with other plant receptor kinases and, potentially their ligands. "There must be some advantage to having all this different functions combined into a single helper protein", Hothorn speculates. Notably, the use of a shared helper protein could allow different signalling pathway to communicate with each other.

The atomic models offer other novel insights too: "Looking at our models, we can now predict pretty well, which mutation in the receptor or helper protein should have an effect on the down-stream signalling pathway. We also know what parts of the hormone are really important to make it bind to the receptor or to the helper protein". Such detailed insights may promote the rational design of synthetic plant steroid hormones and receptor antagonist with applications in basic research, and perhaps someday in the field.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Relugolix and radiation therapy may be a safe, effective combination for treating prostate cancer